BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12046074)

  • 1. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
    Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
    World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
    Imazeki F; Yokosuka O; Ohto M; Omata M
    J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan.
    Nose H; Imazeki F; Ohto M; Omata M
    Cancer; 1993 Jul; 72(2):355-60. PubMed ID: 8100480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China].
    Ming L; Yuan B; Thorgeirsson SS
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A molecular pathological study of p53 gene in hepatocellular carcinoma].
    Zhao P
    Zhonghua Bing Li Xue Za Zhi; 1993 Feb; 22(1):16-8. PubMed ID: 8101139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
    Goldblum JR; Bartos RE; Carr KA; Frank TS
    Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations of p53 gene in human hepatocellular carcinoma from China.
    Li D; Cao Y; He L; Wang NJ; Gu JR
    Carcinogenesis; 1993 Feb; 14(2):169-73. PubMed ID: 8382111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
    Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.
    Yang M; Zhou H; Kong RY; Fong WF; Ren LQ; Liao XH; Wang Y; Zhuang W; Yang S
    Mutat Res; 1997 Nov; 381(1):25-9. PubMed ID: 9403027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China].
    Zhang F; Zhu Y; Sun Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):18-21. PubMed ID: 10921048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.